Evidence map›Paper›PMID 29324705›Full record

Trial reportNutrients2018

Influence of Chitosan Treatment on Surrogate Serum Markers of Cholesterol Metabolism in Obese Subjects.

Dieter Lütjohann, Milka Marinova, Karsten Wolter, Winfried Willinek, Norman Bitterlich, Martin Coenen, Christoph Coch, Frans Stellaard

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Effect of Chitosan on the Number ofInternational journal of molecular sciences · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Dieter LütjohannInstitute for Clinical Chemistry and Clinical Pharmacology, University Clinics of Bonn, D-53127 Bonn, Germany. dieter.luetjohann@ukbonn.de.
Milka MarinovaDepartment of Radiology, University Clinics of Bonn, D-53127 Bonn, Germany. milka.marinova@ukb.uni-bonn.de.
Karsten WolterDepartment of Radiology, University Clinics of Bonn, D-53127 Bonn, Germany. karsten.wolter@ukb.uni-bonn.de.
Winfried WillinekDepartment of Radiology, University Clinics of Bonn, D-53127 Bonn, Germany. w.willinek@bk-trier.de.
Norman BitterlichMedizin & Service GmbH, Abt. Biostatistik, Boettcherstraße 10, D-09117 Chemnitz, Germany. bitterlich@medizinservice-sachsen.de.
Martin CoenenInstitute for Clinical Chemistry and Clinical Pharmacology, University Clinics of Bonn, D-53127 Bonn, Germany. martin.coenen@ukb.uni-bonn.de.
Christoph CochInstitute for Clinical Chemistry and Clinical Pharmacology, University Clinics of Bonn, D-53127 Bonn, Germany. ccoch@uni-bonn.de.
Frans StellaardInstitute for Clinical Chemistry and Clinical Pharmacology, University Clinics of Bonn, D-53127 Bonn, Germany. fstellaard@hotmail.com.
University Hospital Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chitosan treatment results in significantly lower serum low density lipoprotein (LDL) cholesterol concentrations. To assess the working mechanisms of chitosan, we measured serum surrogate markers of cholesterol absorption (campesterol, sitosterol, cholestanol), synthesis (lathosterol, lanosterol, desmosterol), and degradation to bile acids (7α-hydroxy-cholesterol, 27-hydroxy-cholesterol), corrected for cholesterol concentration (R_sterols). Over 12 weeks, 116 obese subjects (Body Mass Index, BMI 31.7, range 28.1-38.9 kg/m²) were studied under chitosan (

Indexed as

AdolescentAdultAgedAnticholesteremic AgentsBile Acids and SaltsBiomarkersChitosanCholesterolDouble-Blind MethodFemaleGermanyHumansLipid MetabolismMaleMiddle AgedObesityAnticholesteremic AgentsBile Acids and SaltsBiomarkersChitosanCholesterolbile acid synthesischolesterol absorptioncholesterol synthesislathosterollipid loweringlipoproteinsoxysterolsphytosterolsplaceboplant sterols

Identifiers

PMID29324705
PMCPMC5793300
OpenAlexW2783045696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.